{"id": "article-140018_0", "title": "Pyocystis -- Continuing Education Activity", "content": "Pyocystis is a severe form of lower urinary tract infection that results from the collection of purulent debris within the bladder. Pyocystis is sometimes referred to in the literature as \u2018empyema cystis\u2019 and \u2018vesical empyema.\u2019 Pyocystis is an uncommon condition that occurs exclusively in the defunctionalized bladder. It can cause a severe systemic infection and result in prolonged hospital stays, surgery, and death. To optimize outcomes and reduce morbidity, early identification and treatment must occur. This activity reviews the evaluation and treatment of patients with pyocystis and highlights the role of the interprofessional team in evaluating and treating patients with this condition.", "contents": "Pyocystis -- Continuing Education Activity. Pyocystis is a severe form of lower urinary tract infection that results from the collection of purulent debris within the bladder. Pyocystis is sometimes referred to in the literature as \u2018empyema cystis\u2019 and \u2018vesical empyema.\u2019 Pyocystis is an uncommon condition that occurs exclusively in the defunctionalized bladder. It can cause a severe systemic infection and result in prolonged hospital stays, surgery, and death. To optimize outcomes and reduce morbidity, early identification and treatment must occur. This activity reviews the evaluation and treatment of patients with pyocystis and highlights the role of the interprofessional team in evaluating and treating patients with this condition."}
{"id": "article-140018_1", "title": "Pyocystis -- Continuing Education Activity", "content": "Objectives: Outline the pathophysiology of pyocystis. Identify the risk factors that make a patient susceptible to developing pyocystis. Summarize the treatment options for patients with pyocystis. Describe the Spence-Allen procedure and its role in the management of pyocystis. Access free multiple choice questions on this topic.", "contents": "Pyocystis -- Continuing Education Activity. Objectives: Outline the pathophysiology of pyocystis. Identify the risk factors that make a patient susceptible to developing pyocystis. Summarize the treatment options for patients with pyocystis. Describe the Spence-Allen procedure and its role in the management of pyocystis. Access free multiple choice questions on this topic."}
{"id": "article-140018_2", "title": "Pyocystis -- Introduction", "content": "Pyocystis is a rare but severe lower urinary tract infection resulting in a collection of infected debris accumulating within the bladder. [1] Other terms used for this condition are\u00a0\u2018vesical empyema\u2019 and \u2018empyema cystis.\u2019 [2] [3] Most frequently, this condition occurs in the defunctionalized bladder\u00a0of patients who have undergone a pre-vesicular urinary diversion procedure without a subsequent cystectomy. [1] These patients may have either a continent, categorizable diversion, or a urostomy (usually ileal conduit). [4]", "contents": "Pyocystis -- Introduction. Pyocystis is a rare but severe lower urinary tract infection resulting in a collection of infected debris accumulating within the bladder. [1] Other terms used for this condition are\u00a0\u2018vesical empyema\u2019 and \u2018empyema cystis.\u2019 [2] [3] Most frequently, this condition occurs in the defunctionalized bladder\u00a0of patients who have undergone a pre-vesicular urinary diversion procedure without a subsequent cystectomy. [1] These patients may have either a continent, categorizable diversion, or a urostomy (usually ileal conduit). [4]"}
{"id": "article-140018_3", "title": "Pyocystis -- Introduction", "content": "In the context of bladder cancer, patients who have supra-vesical diversion usually have a cystectomy. [5] Indications for supra-vesical diversion without cystectomy are usually for benign disease and include; refractory ureteral obstruction, neurogenic bladder, radiation cystitis, hemorrhagic cystitis, or interstitial cystitis. [6] Pyocystis can also occur in patients with a physiologically defunctionalized bladder secondary to anuria, such as in patients with end-stage renal failure. [7]", "contents": "Pyocystis -- Introduction. In the context of bladder cancer, patients who have supra-vesical diversion usually have a cystectomy. [5] Indications for supra-vesical diversion without cystectomy are usually for benign disease and include; refractory ureteral obstruction, neurogenic bladder, radiation cystitis, hemorrhagic cystitis, or interstitial cystitis. [6] Pyocystis can also occur in patients with a physiologically defunctionalized bladder secondary to anuria, such as in patients with end-stage renal failure. [7]"}
{"id": "article-140018_4", "title": "Pyocystis -- Introduction", "content": "Though mild cases of pyocystis can be managed with conservative treatments of broad-spectrum antibiotics and intermittent bladder irrigation, a cystectomy may be\u00a0necessary in cases with resistant infection. There is some debate about whether a cystectomy should be offered at the time of urinary diversion procedures in some cohorts of patients. This is not currently a recommended preventative intervention due to the rarity of pyocystis occurring even in cohorts most at risk relative to the risks of cystectomy. [8]", "contents": "Pyocystis -- Introduction. Though mild cases of pyocystis can be managed with conservative treatments of broad-spectrum antibiotics and intermittent bladder irrigation, a cystectomy may be\u00a0necessary in cases with resistant infection. There is some debate about whether a cystectomy should be offered at the time of urinary diversion procedures in some cohorts of patients. This is not currently a recommended preventative intervention due to the rarity of pyocystis occurring even in cohorts most at risk relative to the risks of cystectomy. [8]"}
{"id": "article-140018_5", "title": "Pyocystis -- Introduction", "content": "As pyocytis is a rare condition, there are limited\u00a0case reports describing it and low numbers of patients involved\u00a0in the published meta-analysis. This may affect the statistical validity of analysis on occurrence and treatment outcomes.", "contents": "Pyocystis -- Introduction. As pyocytis is a rare condition, there are limited\u00a0case reports describing it and low numbers of patients involved\u00a0in the published meta-analysis. This may affect the statistical validity of analysis on occurrence and treatment outcomes."}
{"id": "article-140018_6", "title": "Pyocystis -- Etiology", "content": "Pyocytis most likely occurs due to the inability of a defunctionalized bladder to expel the epithelial cells and debris that accumulate in the bladder without the flow of urine. [9] It could also be due to the collection of retrograde prostatic secretions in men and the osmotic transfer of water. [10] When this collection of debris/secretions becomes infected, pyocystis occurs.", "contents": "Pyocystis -- Etiology. Pyocytis most likely occurs due to the inability of a defunctionalized bladder to expel the epithelial cells and debris that accumulate in the bladder without the flow of urine. [9] It could also be due to the collection of retrograde prostatic secretions in men and the osmotic transfer of water. [10] When this collection of debris/secretions becomes infected, pyocystis occurs."}
{"id": "article-140018_7", "title": "Pyocystis -- Etiology", "content": "In a fully functional bladder, the flow of urine prevents the accumulation of debris and subsequent inflammatory and infective processes occurring. Causative organisms are frequently the same as those that most commonly cause lower urinary tract infections, such as E.coli and other gram-negative bacteria. Other common organisms include P. mirabilis , P. aeuginosa , and Enterococcus . [11] [12] Retrograde passage of these organisms along the urethra is the most likely source of infection. [6]", "contents": "Pyocystis -- Etiology. In a fully functional bladder, the flow of urine prevents the accumulation of debris and subsequent inflammatory and infective processes occurring. Causative organisms are frequently the same as those that most commonly cause lower urinary tract infections, such as E.coli and other gram-negative bacteria. Other common organisms include P. mirabilis , P. aeuginosa , and Enterococcus . [11] [12] Retrograde passage of these organisms along the urethra is the most likely source of infection. [6]"}
{"id": "article-140018_8", "title": "Pyocystis -- Etiology", "content": "The bladder can become\u00a0defunctionalized either iatrogenically or physiologically. Physiological defunctioning occurs because of anuria secondary to end-stage renal failure. Iatrogenic defunctioning results from supravesical urinary diversion. Both result in a lack of urine flushing through the bladder, putting the patient at risk of pyocystis. [13] [9]", "contents": "Pyocystis -- Etiology. The bladder can become\u00a0defunctionalized either iatrogenically or physiologically. Physiological defunctioning occurs because of anuria secondary to end-stage renal failure. Iatrogenic defunctioning results from supravesical urinary diversion. Both result in a lack of urine flushing through the bladder, putting the patient at risk of pyocystis. [13] [9]"}
{"id": "article-140018_9", "title": "Pyocystis -- Epidemiology", "content": "The incidence of pyocytis rose following the introduction of supravesical urinary diversion procedures in the 1960s. Reported cases prior to this were rare. The incidence of pyocytis in patients with end-stage\u00a0renal disease is unclear in the published literature, but it\u00a0is a known complication secondary to anuria in this patient cohort. [9] [5]", "contents": "Pyocystis -- Epidemiology. The incidence of pyocytis rose following the introduction of supravesical urinary diversion procedures in the 1960s. Reported cases prior to this were rare. The incidence of pyocytis in patients with end-stage\u00a0renal disease is unclear in the published literature, but it\u00a0is a known complication secondary to anuria in this patient cohort. [9] [5]"}
{"id": "article-140018_10", "title": "Pyocystis -- Epidemiology", "content": "Pyocystis resulting from iatrogenic bladder defunctioning is more common than from end-stage renal failure. [6] The reported rate of occurrence of pyocytis varies from 7 to 67% in patients who have had a urinary diversion procedure. [11] [14] [2] [15] It has also been observed to be more common in female populations. [16] The reason for this is thought to be the shorter female urethra,\u00a0similar to how women are more at risk of urinary tract infections. [5]", "contents": "Pyocystis -- Epidemiology. Pyocystis resulting from iatrogenic bladder defunctioning is more common than from end-stage renal failure. [6] The reported rate of occurrence of pyocytis varies from 7 to 67% in patients who have had a urinary diversion procedure. [11] [14] [2] [15] It has also been observed to be more common in female populations. [16] The reason for this is thought to be the shorter female urethra,\u00a0similar to how women are more at risk of urinary tract infections. [5]"}
{"id": "article-140018_11", "title": "Pyocystis -- Epidemiology", "content": "Culturing of proteus mirabilis in the urine prior to supravesical diversion has been implicated with higher risks of developing pyocystis. [17] [3] Pyocystis develops more often in the first 6\u00a0to 12 months following surgery. [17] Some studies have shown that there is a significantly increased risk of developing pyocystis if the patient has had pelvic irradiation. [18] [19]", "contents": "Pyocystis -- Epidemiology. Culturing of proteus mirabilis in the urine prior to supravesical diversion has been implicated with higher risks of developing pyocystis. [17] [3] Pyocystis develops more often in the first 6\u00a0to 12 months following surgery. [17] Some studies have shown that there is a significantly increased risk of developing pyocystis if the patient has had pelvic irradiation. [18] [19]"}
{"id": "article-140018_12", "title": "Pyocystis -- Epidemiology", "content": "Pyocystis is also described as empyema cystis and vesical empyema, though these terms are infrequently used and often used in older descriptions of the condition. [20] [3] Because of this, their contribution to epidemiological literature is limited.", "contents": "Pyocystis -- Epidemiology. Pyocystis is also described as empyema cystis and vesical empyema, though these terms are infrequently used and often used in older descriptions of the condition. [20] [3] Because of this, their contribution to epidemiological literature is limited."}
{"id": "article-140018_13", "title": "Pyocystis -- Pathophysiology", "content": "The accumulation of cellular debris provides a focus for bacterial infection. [1] If bacterial infection occurs, pus accumulates due to bacterial cell turnover and the host\u2019s inflammatory response. This collection of pus in the bladder is pyocystis. The collection of infected tissue results in the activation of the body\u2019s immune response leading to pain, fevers, and systemic inflammatory response syndrome in severe cases. [1]", "contents": "Pyocystis -- Pathophysiology. The accumulation of cellular debris provides a focus for bacterial infection. [1] If bacterial infection occurs, pus accumulates due to bacterial cell turnover and the host\u2019s inflammatory response. This collection of pus in the bladder is pyocystis. The collection of infected tissue results in the activation of the body\u2019s immune response leading to pain, fevers, and systemic inflammatory response syndrome in severe cases. [1]"}
{"id": "article-140018_14", "title": "Pyocystis -- Pathophysiology", "content": "Much like with an abscess or empyema, the body will struggle to get control of the infection due to the difficulty of getting white cells into the purulent fluid. Therefore to manage pyocystis, the purulent tissue must be drained.", "contents": "Pyocystis -- Pathophysiology. Much like with an abscess or empyema, the body will struggle to get control of the infection due to the difficulty of getting white cells into the purulent fluid. Therefore to manage pyocystis, the purulent tissue must be drained."}
{"id": "article-140018_15", "title": "Pyocystis -- History and Physical", "content": "Pyocytis will typically present with suprapubic pain, malodorous discharge from the urethra, and fevers for several days prior to admission. [12] In more severe cases, there may also be other systemic signs of infection, such as loss of appetite, nausea, and vomiting. [12]", "contents": "Pyocystis -- History and Physical. Pyocytis will typically present with suprapubic pain, malodorous discharge from the urethra, and fevers for several days prior to admission. [12] In more severe cases, there may also be other systemic signs of infection, such as loss of appetite, nausea, and vomiting. [12]"}
{"id": "article-140018_16", "title": "Pyocystis -- History and Physical", "content": "Patients presenting with signs of systemic infection and accompanying risk factors should be investigated and treated for pyocystis. These risk factors include surgical defunctioning of the bladder or end-stage renal failure. Alternatively, patients with pyocystis may\u00a0present with a low-grade fever and some abdominal or pelvic discomfort and may be systemically well. There is a spectrum of presentations for this condition depending on the severity and duration of infection. [21] [22]", "contents": "Pyocystis -- History and Physical. Patients presenting with signs of systemic infection and accompanying risk factors should be investigated and treated for pyocystis. These risk factors include surgical defunctioning of the bladder or end-stage renal failure. Alternatively, patients with pyocystis may\u00a0present with a low-grade fever and some abdominal or pelvic discomfort and may be systemically well. There is a spectrum of presentations for this condition depending on the severity and duration of infection. [21] [22]"}
{"id": "article-140018_17", "title": "Pyocystis -- History and Physical", "content": "On examination of the abdomen, there may be a palpable, tender suprapubic mass and inguinal lymphadenopathy. [22] On inspection of the genitalia, malodorous discharge or frank pus may come from the urethra. [17] The clinician may find tachycardia, hypotension, and pyrexia when taking basic vital signs. [21]", "contents": "Pyocystis -- History and Physical. On examination of the abdomen, there may be a palpable, tender suprapubic mass and inguinal lymphadenopathy. [22] On inspection of the genitalia, malodorous discharge or frank pus may come from the urethra. [17] The clinician may find tachycardia, hypotension, and pyrexia when taking basic vital signs. [21]"}
{"id": "article-140018_18", "title": "Pyocystis -- Evaluation", "content": "Blood tests often show leukocytosis and a raised C-reactive protein (CRP). [13] Blood cultures should be taken; however, these often do not isolate an organism. [9] [21] All patients with a differential of pyocytis should be catheterized. This has dual diagnostic and therapeutic benefits. A sample of the bladder contents should be taken for microbiology, cultures, and sensitivities. Most common organisms isolated are E . coli , Pseudomonas aeruginosa, and Enterococcus faecalis . Proteus mirabilis and Serratia marcescens have also been isolated. [12] However, in immunocompromised patients, less common pathogens may be isolated. [21]", "contents": "Pyocystis -- Evaluation. Blood tests often show leukocytosis and a raised C-reactive protein (CRP). [13] Blood cultures should be taken; however, these often do not isolate an organism. [9] [21] All patients with a differential of pyocytis should be catheterized. This has dual diagnostic and therapeutic benefits. A sample of the bladder contents should be taken for microbiology, cultures, and sensitivities. Most common organisms isolated are E . coli , Pseudomonas aeruginosa, and Enterococcus faecalis . Proteus mirabilis and Serratia marcescens have also been isolated. [12] However, in immunocompromised patients, less common pathogens may be isolated. [21]"}
{"id": "article-140018_19", "title": "Pyocystis -- Evaluation", "content": "The diagnosis of pyocytis can be aided by using computed tomography (CT) and ultrasound. The benefit of ultrasound is that it is more easily accessed and can be performed at the bedside. Ultrasound will show a thickened bladder wall and a heterogeneous echogenic collection. [13] CT scanning may show a thick-walled bladder containing a collection of fluid. [22] CT scanning with IV contrast is preferred for investigation. However, non-contrast CT will display the same features and is useful in patients with end-stage renal failure. [22] [2] [9] Investigation and diagnosis of pyocytis\u00a0may also include cystoscopy to aid bladder access, evacuate toxic collections, and biopsy\u00a0thick-walled bladder to exclude malignancy. [4] [2]", "contents": "Pyocystis -- Evaluation. The diagnosis of pyocytis can be aided by using computed tomography (CT) and ultrasound. The benefit of ultrasound is that it is more easily accessed and can be performed at the bedside. Ultrasound will show a thickened bladder wall and a heterogeneous echogenic collection. [13] CT scanning may show a thick-walled bladder containing a collection of fluid. [22] CT scanning with IV contrast is preferred for investigation. However, non-contrast CT will display the same features and is useful in patients with end-stage renal failure. [22] [2] [9] Investigation and diagnosis of pyocytis\u00a0may also include cystoscopy to aid bladder access, evacuate toxic collections, and biopsy\u00a0thick-walled bladder to exclude malignancy. [4] [2]"}
{"id": "article-140018_20", "title": "Pyocystis -- Treatment / Management", "content": "In patients displaying signs of urosepsis, initial treatment should include fluid resuscitation and administration of broad-spectrum IV antibiotics. [21] High-risk patients should be treated with antibiotics that cover opportunistic infections. High-risk patients include those who are receiving dialysis, chemotherapy, IV antibiotics, or\u00a0who have recently been discharged from the hospital. [1] Some patients may have pre-existing urine cultures; these sensitivities will help guide treatment.", "contents": "Pyocystis -- Treatment / Management. In patients displaying signs of urosepsis, initial treatment should include fluid resuscitation and administration of broad-spectrum IV antibiotics. [21] High-risk patients should be treated with antibiotics that cover opportunistic infections. High-risk patients include those who are receiving dialysis, chemotherapy, IV antibiotics, or\u00a0who have recently been discharged from the hospital. [1] Some patients may have pre-existing urine cultures; these sensitivities will help guide treatment."}
{"id": "article-140018_21", "title": "Pyocystis -- Treatment / Management", "content": "Immediate catheterization of the patient is important in patients with suspected pyocystis. This has dual therapeutic and diagnostic benefits through drainage of infected tissue and acquiring pus for culture, respectively. Once sensitivities are obtained, the antibiotic choice can be tailored to reflect this.", "contents": "Pyocystis -- Treatment / Management. Immediate catheterization of the patient is important in patients with suspected pyocystis. This has dual therapeutic and diagnostic benefits through drainage of infected tissue and acquiring pus for culture, respectively. Once sensitivities are obtained, the antibiotic choice can be tailored to reflect this."}
{"id": "article-140018_22", "title": "Pyocystis -- Treatment / Management", "content": "Following catheterization, bladder irrigation should be used to prevent the re-accumulation of infected debris and to assist in clearing the initial collection. This can be continuous irrigation using a three-way catheter or can be done using frequent bladder washouts. Irrigation should be continued in the community for up to 3 months, several times a week, to\u00a0attempt to eradicate any infection. [12] Intra-vesical antibiotics have been used to treat pyocytis, typically gentamycin or neomycin. Normal saline is also an option. [23] [17] [24]", "contents": "Pyocystis -- Treatment / Management. Following catheterization, bladder irrigation should be used to prevent the re-accumulation of infected debris and to assist in clearing the initial collection. This can be continuous irrigation using a three-way catheter or can be done using frequent bladder washouts. Irrigation should be continued in the community for up to 3 months, several times a week, to\u00a0attempt to eradicate any infection. [12] Intra-vesical antibiotics have been used to treat pyocytis, typically gentamycin or neomycin. Normal saline is also an option. [23] [17] [24]"}
{"id": "article-140018_23", "title": "Pyocystis -- Treatment / Management", "content": "The previous positive urine culture of Proteus mirabilis is a significant risk factor for the development of pyocystis following urinary diversion procedures. [25] Some have argued that patients with positive pre-operative urine culture for Proteus mirabilis should be considered for a cystectomy. [5] Alternatively, in sexually inactive females, the Spence-Allen procedure can be considered to prevent the development of pyocytis. [3] [17] This involves the creation of a vesicovaginal\u00a0fistula to allow continuous drainage of bladder contents through the vagina. [26] Cystectomy may be\u00a0necessary for patients not responding to IV antibiotics and irrigation. The need for cystectomy in patients with pyocytis is reportedly up to 25%. [4] [15]", "contents": "Pyocystis -- Treatment / Management. The previous positive urine culture of Proteus mirabilis is a significant risk factor for the development of pyocystis following urinary diversion procedures. [25] Some have argued that patients with positive pre-operative urine culture for Proteus mirabilis should be considered for a cystectomy. [5] Alternatively, in sexually inactive females, the Spence-Allen procedure can be considered to prevent the development of pyocytis. [3] [17] This involves the creation of a vesicovaginal\u00a0fistula to allow continuous drainage of bladder contents through the vagina. [26] Cystectomy may be\u00a0necessary for patients not responding to IV antibiotics and irrigation. The need for cystectomy in patients with pyocytis is reportedly up to 25%. [4] [15]"}
{"id": "article-140018_24", "title": "Pyocystis -- Differential Diagnosis", "content": "In females with pyocytis urethral discharge can be accidentally misidentified as vaginal discharge,\u00a0leading to misdiagnosis. [27]", "contents": "Pyocystis -- Differential Diagnosis. In females with pyocytis urethral discharge can be accidentally misidentified as vaginal discharge,\u00a0leading to misdiagnosis. [27]"}
{"id": "article-140018_25", "title": "Pyocystis -- Prognosis", "content": "The prognosis\u00a0of pyocystis depends on the severity of the infection and systemic involvement. Milder cases\u00a0may be managed in the community with antibiotics and intermittent bladder irrigation. Severe non-resolving infections require surgical management with either the Spence-Allen procedure or total cystectomy.", "contents": "Pyocystis -- Prognosis. The prognosis\u00a0of pyocystis depends on the severity of the infection and systemic involvement. Milder cases\u00a0may be managed in the community with antibiotics and intermittent bladder irrigation. Severe non-resolving infections require surgical management with either the Spence-Allen procedure or total cystectomy."}
{"id": "article-140018_26", "title": "Pyocystis -- Prognosis", "content": "The need for a cystectomy in patients diagnosed with pyocytis is reported to be between 18.7% and 25%, however, due to the relative rarity of the condition, the number of cases in the studies was low, and a meta-analysis of a larger patient cohort is required to establish more accurate figures. [4] [15]", "contents": "Pyocystis -- Prognosis. The need for a cystectomy in patients diagnosed with pyocytis is reported to be between 18.7% and 25%, however, due to the relative rarity of the condition, the number of cases in the studies was low, and a meta-analysis of a larger patient cohort is required to establish more accurate figures. [4] [15]"}
{"id": "article-140018_27", "title": "Pyocystis -- Complications", "content": "Complications of pyocytis include the need for surgical management, including the need for a total cystectomy. Sepsis and the corresponding complication can also occur in patients with pyocystis and can result in death. [12]", "contents": "Pyocystis -- Complications. Complications of pyocytis include the need for surgical management, including the need for a total cystectomy. Sepsis and the corresponding complication can also occur in patients with pyocystis and can result in death. [12]"}
{"id": "article-140018_28", "title": "Pyocystis -- Deterrence and Patient Education", "content": "Pyocystis is a severe condition that can result in prolonged hospital stays, significant additional surgery, and death. Patients at risk of it should be informed of this and the common symptoms. These symptoms include suprapubic pain, malodorous discharge, and fevers. Patients at risk of pyocystis include those who have had surgical defunctioning of the bladder or have anuria because of renal failure.", "contents": "Pyocystis -- Deterrence and Patient Education. Pyocystis is a severe condition that can result in prolonged hospital stays, significant additional surgery, and death. Patients at risk of it should be informed of this and the common symptoms. These symptoms include suprapubic pain, malodorous discharge, and fevers. Patients at risk of pyocystis include those who have had surgical defunctioning of the bladder or have anuria because of renal failure."}
{"id": "article-140018_29", "title": "Pyocystis -- Deterrence and Patient Education", "content": "High-risk patients of these groups include those who are also on dialysis, immunosuppressed, or have a previous culture for proteus mirabilis. Management of other medical conditions and lifestyle factors such as smoking and diabetes may also be of benefit. [13] [7]", "contents": "Pyocystis -- Deterrence and Patient Education. High-risk patients of these groups include those who are also on dialysis, immunosuppressed, or have a previous culture for proteus mirabilis. Management of other medical conditions and lifestyle factors such as smoking and diabetes may also be of benefit. [13] [7]"}
{"id": "article-140018_30", "title": "Pyocystis -- Deterrence and Patient Education", "content": "Rapid identification and treatment of pyocystis are crucial to the successful medical management of pyocystis. Delayed intervention may result in the need for surgical intervention and a poorer prognosis. [12]", "contents": "Pyocystis -- Deterrence and Patient Education. Rapid identification and treatment of pyocystis are crucial to the successful medical management of pyocystis. Delayed intervention may result in the need for surgical intervention and a poorer prognosis. [12]"}
{"id": "article-140018_31", "title": "Pyocystis -- Pearls and Other Issues", "content": "Many of these patients have a complex urological history with multiple, complex procedures throughout childhood into adult life. The patient may not be aware or able to communicate their anatomical bladder remains in situ hence why it can be ignored as a source during septic episodes. Always consider pyocystis in atypical or recurrent infections in patients with prior urinary diversion.", "contents": "Pyocystis -- Pearls and Other Issues. Many of these patients have a complex urological history with multiple, complex procedures throughout childhood into adult life. The patient may not be aware or able to communicate their anatomical bladder remains in situ hence why it can be ignored as a source during septic episodes. Always consider pyocystis in atypical or recurrent infections in patients with prior urinary diversion."}
{"id": "article-140018_32", "title": "Pyocystis -- Enhancing Healthcare Team Outcomes", "content": "All members of the interprofessional health care team involved in the care of the above patient cohorts who are susceptible to developing pyocytis must be aware of it as a complication. They should also be aware of what puts those patients at higher risk of developing it. The team can be comprised of clinicians (MDs, DOs, NPs, and PAs), specialists (infectious disease, urology), nursing staff, and pharmacists, which may include an infectious disease specialty pharmacist. All team members must engage in open communication and meticulous record keeping of each patient encounter and report to other team members if there are any patient status changes or concerns. This interprofessional paradigm will help optimize patient outcomes. [Level 5]", "contents": "Pyocystis -- Enhancing Healthcare Team Outcomes. All members of the interprofessional health care team involved in the care of the above patient cohorts who are susceptible to developing pyocytis must be aware of it as a complication. They should also be aware of what puts those patients at higher risk of developing it. The team can be comprised of clinicians (MDs, DOs, NPs, and PAs), specialists (infectious disease, urology), nursing staff, and pharmacists, which may include an infectious disease specialty pharmacist. All team members must engage in open communication and meticulous record keeping of each patient encounter and report to other team members if there are any patient status changes or concerns. This interprofessional paradigm will help optimize patient outcomes. [Level 5]"}
{"id": "article-140018_33", "title": "Pyocystis -- Enhancing Healthcare Team Outcomes", "content": "The importance of identification of urethral discharge as opposed to vaginal discharge is an important differentiator for pyocystis to allow correct management to occur. Rapid identification in the community of the condition as a differential is essential for timely investigation, diagnosis, and intervention. Education about this rare condition is crucial to avoid\u00a0potential complications in this patient cohort.", "contents": "Pyocystis -- Enhancing Healthcare Team Outcomes. The importance of identification of urethral discharge as opposed to vaginal discharge is an important differentiator for pyocystis to allow correct management to occur. Rapid identification in the community of the condition as a differential is essential for timely investigation, diagnosis, and intervention. Education about this rare condition is crucial to avoid\u00a0potential complications in this patient cohort."}
{"id": "article-140018_34", "title": "Pyocystis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Pyocystis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}